Menu
Live
Video-Archiv
Breastcancer
ESMO 2022: Interviews von Renate Haidinger, Brustkrebs Deutschland e.V.
Gastrointestinal Tumours
Statement Highlights Metastatic Gastrointestinal Cancer - Dr. med. Sara De Dosso, Bellinzona & Dr. med. Alexander Siebenhüner, Schaffhausen
Kongressberichte
Aktuelle Kongressberichte
EHA2023 Congress
ASCO Annual Meeting, June 2-6, 2023 - McCormick Place, Chicago - Abstract Titles now available
Comprehensive Cancer Center Zürich: Patientenakademie – Brustkrebs
18th St.Gallen International Breast Cancer Conference 2023 (SGBCC)
ASCO Genitourinary Cancers Symposium 2023
ASCO 2023 Gastrointestinal (GI) Cancers Symposium
Kongressberichte 2022
64th ASH Annual Meeting and Exposition - December 10-13, 2022
45th SAN ANTONIO BREAST CANCER SYMPOSIUM - December 6 - 10, 2022, San Antonio Texas
Cancer Academy Multiples Myelom
ESMO Congress 2022 - 9. - 13. SEPTEMBER - PARIS, FRANCE
19th International Myeloma Society Annual Meeting - Los Angeles, August 25-27, 2022
World Conference on Lung Cancer - AUGUST 6 - 9, 2022, VIENNA, AUSTRIA
ESMO World Congress on Gastrointestinal Cancer (ESMO World GI 2022)
EHA2022 Congress
ASCO Annual Meeting, June 3-7, 2022 - McCormick Place, Chicago
SAMO Interdisciplinary Workshop on Breast Tumors 2022
Druggable in 2022: Wie neue zielgerichtete Therapien die Behandlung bei fortgeschrittenem NSCLC verändern
3rd European Myeloma Network Meeting
AGO - MAMMAKARZINOM STATE OF THE ART
Wie neue zielgerichtete Therapien die Behandlung beim fortgeschrittenen NSCLC (r)evolutionieren.
EBMT (48th Annual Meeting of the European Society for Blood and Marrow Transplantation)
SAMO Highlights of the Year 2021
Brustrebsinfotag
SAMO Masterclass I 2022
ASCO Genitourinary Cancers Symposium 2022
EBMT-EHA 4th European CAR T-Cell Meeting
ASCO Gastrointestinal Cancers Symposium
Kongressberichte Archiv
63rd ASH Annual Meeting and Exposition - December 11-14, 2021
SAN ANTONIO BREAST CANCER SYMPOSIUM - December 7 - 11, 2021, San Antonio Texas
9. Interdisziplinäres Prostatakarzinom-Symposium, St. Gallen, 2. Dezember 2021
Kongressberichte Archiv 2021
Kongressberichte Archiv 2020
Kongressberichte Archiv 2019
Kongressberichte Archiv 2018
Kongressberichte Archiv 2017
Kalender
Krebstherapie
Alle Wirkstoffe
Behandlungsguidelines
Link to Medical Journals
Interaktionsprüfungen
Cancer Cell Line Encyclopedia
Krebserkrankungen (Entstehung, Verlauf, Therapie & Prävention)
Organisationen
Netzwerke
Fachgesellschaften
Info für PatientINNen
Science Board
Datenschutzbestimmungen
Impressum
Zustimmen
Nicht zustimmen
Bild/Picture® shutterstock.com
SAMO Interdisciplinary Workshop on Urogenital Tumors 2023
Oncoletter
Kalender
Eventreader
SAMO Interdisciplinary Workshop on Urogenital Tumors 2023
29. September 2023 - 30. September 2023
Ort
: Luzern, Seehotel Hermitage, Schweiz
SAMO Website
Zurück
Copyright 2023. All Rights Reserved.
Datenschutzbestimmungen
Live
Video-Archiv
Breastcancer
ESMO 2022: Interviews von Renate Haidinger, Brustkrebs Deutschland e.V.
Gastrointestinal Tumours
Statement Highlights Metastatic Gastrointestinal Cancer - Dr. med. Sara De Dosso, Bellinzona & Dr. med. Alexander Siebenhüner, Schaffhausen
Kongressberichte
2023
EHA2023 Congress
ASCO Annual Meeting, June 2-6, 2023 - McCormick Place, Chicago - Abstract Titles now available
Comprehensive Cancer Center Zürich: Patientenakademie – Brustkrebs
18th St.Gallen International Breast Cancer Conference 2023 (SGBCC)
ASCO Genitourinary Cancers Symposium 2023
ASCO 2023 Gastrointestinal (GI) Cancers Symposium
2022
64th ASH Annual Meeting and Exposition - December 10-13, 2022
45th SAN ANTONIO BREAST CANCER SYMPOSIUM - December 6 - 10, 2022, San Antonio Texas
Cancer Academy Multiples Myelom
ESMO Congress 2022 - 9. - 13. SEPTEMBER - PARIS, FRANCE
19th International Myeloma Society Annual Meeting - Los Angeles, August 25-27, 2022
World Conference on Lung Cancer - AUGUST 6 - 9, 2022, VIENNA, AUSTRIA
ESMO World Congress on Gastrointestinal Cancer (ESMO World GI 2022)
EHA2022 Congress
ASCO Annual Meeting, June 3-7, 2022 - McCormick Place, Chicago
SAMO Interdisciplinary Workshop on Breast Tumors 2022
Druggable in 2022: Wie neue zielgerichtete Therapien die Behandlung bei fortgeschrittenem NSCLC verändern
3rd European Myeloma Network Meeting
AGO - MAMMAKARZINOM STATE OF THE ART
Wie neue zielgerichtete Therapien die Behandlung beim fortgeschrittenen NSCLC (r)evolutionieren.
EBMT (48th Annual Meeting of the European Society for Blood and Marrow Transplantation)
SAMO Highlights of the Year 2021
Brustrebsinfotag
SAMO Masterclass I 2022
ASCO Genitourinary Cancers Symposium 2022
EBMT-EHA 4th European CAR T-Cell Meeting
ASCO Gastrointestinal Cancers Symposium
2021
63rd ASH Annual Meeting and Exposition - December 11-14, 2021
SAN ANTONIO BREAST CANCER SYMPOSIUM - December 7 - 11, 2021, San Antonio Texas
9. Interdisziplinäres Prostatakarzinom-Symposium, St. Gallen, 2. Dezember 2021
Kongressberichte Archiv 2021
Kongressberichte Archiv 2020
Kongressberichte Archiv 2019
Kongressberichte Archiv 2018
Kongressberichte Archiv 2017
Kalender
Krebstherapie
Alle Wirkstoffe
Behandlungsguidelines
Link to Medical Journals
Interaktionsprüfungen
Cancer Cell Line Encyclopedia
Krebserkrankungen (Entstehung, Verlauf, Therapie & Prävention)
Organisationen
Netzwerke
Fachgesellschaften
Info für PatientINNen
Science Board
Menu
Live
Video-Archiv
Breastcancer
ESMO 2022: Interviews von Renate Haidinger, Brustkrebs Deutschland e.V.
Gastrointestinal Tumours
Statement Highlights Metastatic Gastrointestinal Cancer - Dr. med. Sara De Dosso, Bellinzona & Dr. med. Alexander Siebenhüner, Schaffhausen
Kongressberichte
Aktuelle Kongressberichte
EHA2023 Congress
ASCO Annual Meeting, June 2-6, 2023 - McCormick Place, Chicago - Abstract Titles now available
Comprehensive Cancer Center Zürich: Patientenakademie – Brustkrebs
18th St.Gallen International Breast Cancer Conference 2023 (SGBCC)
ASCO Genitourinary Cancers Symposium 2023
ASCO 2023 Gastrointestinal (GI) Cancers Symposium
Kongressberichte 2022
64th ASH Annual Meeting and Exposition - December 10-13, 2022
45th SAN ANTONIO BREAST CANCER SYMPOSIUM - December 6 - 10, 2022, San Antonio Texas
Cancer Academy Multiples Myelom
ESMO Congress 2022 - 9. - 13. SEPTEMBER - PARIS, FRANCE
19th International Myeloma Society Annual Meeting - Los Angeles, August 25-27, 2022
World Conference on Lung Cancer - AUGUST 6 - 9, 2022, VIENNA, AUSTRIA
ESMO World Congress on Gastrointestinal Cancer (ESMO World GI 2022)
EHA2022 Congress
ASCO Annual Meeting, June 3-7, 2022 - McCormick Place, Chicago
SAMO Interdisciplinary Workshop on Breast Tumors 2022
Druggable in 2022: Wie neue zielgerichtete Therapien die Behandlung bei fortgeschrittenem NSCLC verändern
3rd European Myeloma Network Meeting
AGO - MAMMAKARZINOM STATE OF THE ART
Wie neue zielgerichtete Therapien die Behandlung beim fortgeschrittenen NSCLC (r)evolutionieren.
EBMT (48th Annual Meeting of the European Society for Blood and Marrow Transplantation)
SAMO Highlights of the Year 2021
Brustrebsinfotag
SAMO Masterclass I 2022
ASCO Genitourinary Cancers Symposium 2022
EBMT-EHA 4th European CAR T-Cell Meeting
ASCO Gastrointestinal Cancers Symposium
Kongressberichte Archiv
63rd ASH Annual Meeting and Exposition - December 11-14, 2021
SAN ANTONIO BREAST CANCER SYMPOSIUM - December 7 - 11, 2021, San Antonio Texas
9. Interdisziplinäres Prostatakarzinom-Symposium, St. Gallen, 2. Dezember 2021
Kongressberichte Archiv 2021
Kongressberichte Archiv 2020
Kongressberichte Archiv 2019
Kongressberichte Archiv 2018
Kongressberichte Archiv 2017
Kalender
Krebstherapie
Alle Wirkstoffe
Behandlungsguidelines
Link to Medical Journals
Interaktionsprüfungen
Cancer Cell Line Encyclopedia
Krebserkrankungen (Entstehung, Verlauf, Therapie & Prävention)
Organisationen
Netzwerke
Fachgesellschaften
Info für PatientINNen
Science Board
Datenschutzbestimmungen
Impressum
Zustimmen
Nicht zustimmen
Live
Video-Archiv
Breastcancer
ESMO 2022: Interviews von Renate Haidinger, Brustkrebs Deutschland e.V.
Gastrointestinal Tumours
Statement Highlights Metastatic Gastrointestinal Cancer - Dr. med. Sara De Dosso, Bellinzona & Dr. med. Alexander Siebenhüner, Schaffhausen
Kongressberichte
2023
EHA2023 Congress
Webcasts EHA2023 Press Briefing
Plenary Session
Late Breaking Abstracts Session
Acute lymphoblastic leukemia
Acute myeloid leukemia
Aggressive Non-Hodgkin lymphoma
Chronic lymphocytic leukemia
Chronic myeloid leukemia
Myeloma and other monoclonal gammopathies - Clinical
Gene therapy, cellular immunotherapy and vaccination
Hodgkin lymphoma
Indolent and mantle-cell non-Hodgkin lymphoma
Myelodysplastic syndromes
Myeloproliferative neoplasms
Stem cell transplantation
ASCO Annual Meeting, June 2-6, 2023 - McCormick Place, Chicago - Abstract Titles now available
Late-Breaking Abstract -, Plenary - & Highlights of the Day Sessions
Interviews in Kooperation mit info@ONCO-SUISSE, moderiert von Prof. Roger von Moos: Schweizer Experten fassen die ASCO Ergebnisse zusammen
Round Table und Interviews von Renate Haidinger, Brustkrebs Deutschland e.V.
Saturday, June 3 & Sunday June 4, On-Site Press Briefings
Lung Cancer: Oral & Poster Discussion Sessions
Head and Neck Cancer: Oral & Poster Discussion Sessions
Breast Cancer: Oral & Poster Discussion Sessions
Gynecologic Cancer: Oral & Poster Discussion Sessions
Gastrointestinal Cancer: Oral & Poster Discussion Sessions
Sarcoma Cancer: Oral & Poster Discussion Sessions.
Melanoma/Skin Cancers: Oral & Poster Discussion Sessions.
Central Nervous System Tumors: Oral & Poster Discussion Sessions.
Genitourinary Cancer: Oral & Poster Discussion Sessions
Hematologic Malignancies: Oral & Poster Discussion Sessions
Developmental Therapeutics: Oral & Poster Discussion Sessions
Pediatric Oncology: Oral & Poster Discussion Sessions
Comprehensive Cancer Center Zürich: Patientenakademie – Brustkrebs
Neuigkeiten in der Behandlung und Nachsorge bei Brustkrebs
18th St.Gallen International Breast Cancer Conference 2023 (SGBCC)
Interviews von Renate Haidinger, Brustkrebs Deutschland e.V. mit:
ASCO Genitourinary Cancers Symposium 2023
General Sessions
Rapid Abstract Sessions
Oral Abstract Sessions
Statements zu den Highlights des ASCO-GU
ASCO 2023 Gastrointestinal (GI) Cancers Symposium
Rapid Abstract Sessions
Oral Abstract Sessions
Links to more Abstracts
2022
64th ASH Annual Meeting and Exposition - December 10-13, 2022
Plenary Scientific Session
Late-Breaking Abstracts Session
Press Briefing
ASH 2022 Press Briefings: Treating Blood Cancers: Changing the Status Quo & New Drugs, New Targets
ASH 2022 Press Briefings: Late-Breaking Abstracts & Optimizing Pediatric Care
ALL
AML
Acute Myeloid Leukemia: Clinical and Epidemiological
Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies
Acute Myeloid Leukemias: More Abstract Links to Oral Paper Presentations
Lymphoma
Mantle Cell, Follicular, and Other B-Cell Lymphomas
Hodgkin Lymphomas and T/NK cell Lymphomas
Aggressive Lymphomas Prospective Therapeutic Trials
Aggressive Lymphomas: Clinical and Epidemiological
Lymphomas: More Abstract Links to Oral Paper Presentations
CML
Myeloproliferative Syndromes
MDS
CLL
Multiple Myeloma
Multiple Myeloma and Plasma cell Dyscrasias: Clinical and Epidemiological
Multiple Myeloma and Plasma Cell Dyscrasias: Clinical-Prospective Therapeutic Trials
Multiple Myeloma: More Abstract Links to Oral Paper Presentations
Cellular Therapies
More Abstract Links to Oral Papers (Transplantation & Gene Therapies & Outcome Research)
45th SAN ANTONIO BREAST CANCER SYMPOSIUM - December 6 - 10, 2022, San Antonio Texas
Interviews von Renate Haidinger, Brustkrebs Deutschland e.V. mit:
Statements vom SABCS 2022 für Journal Onkologie - Kooperationsprojekt Oncoletter-Journal Onkologie
More Studies from the SABCS 2022 Press Briefing
General Sessions 1-5
Cancer Academy Multiples Myelom
ESMO Congress 2022 - 9. - 13. SEPTEMBER - PARIS, FRANCE
Presidential Symposia I-III
Presidential Symposium I
Presidential Symposium II
Presidential Symposium III
BREAST CANCER
Interviews
Breast cancer, early stage
Breast cancer, metastatic
LUNG CANCER & OTHER THORACIC MALIGNANCIES
Statement Highlights Lung Cancer Prof. Dr. med. Miklos Pless, Winterthur
Non-metastatic NSCLC and other thoracic malignancies
NSCLC, metastatic
HEAD & NECK CANCER
Statement Highlights Head and Neck Cancer - Assoz.-Prof. Priv.-Doz. Dr. Thorsten Füreder, Wien
Head & Neck Sessions
GYNAECOLOGICAL CANCERS
Gynaecological Sessions
CNS TUMOURS & SARCOMA
CNS & SARCOMA Sessions
GENITOURINARY TUMOURS
GU tumours, non-prostate
GU tumours, prostate
GASTROINTESTINAL TUMOURS
Statement Highlights Metastatic Gastrointestinal Cancer - Dr. med. Sara De Dosso, Bellinzona & Dr. med. Alexander Siebenhüner, Schaffhausen
GI, upper digestive
GI, lower digestive
HAEMATOLOGICAL MALIGNANCIES
Haematological malignancies Session
MELANOMA AND OTHER SKIN TUMOURS
Statement Highlights Melanoma and other Skin Cancers - Ao. Univ.-Prof. Dr. Christoph Höller, Wien
Melanoma Sessions
INVESTIGATIONAL IMMUNOTHERAPY
INVESTIGATIONAL IMMUNOTHERAPY
BASIC SCIENCE & TRANSLATIONAL RESEARCH & DEVELOPMENTAL THERAPEUTICS
Basic science & translational research sessions & developmental therapeutics
SUPPORTIVE AND PALLIATIVE CARE
Supportive and palliative care sessions
19th International Myeloma Society Annual Meeting - Los Angeles, August 25-27, 2022
Treatment of Relapsed/Refractory Myeloma
Treatment of Newly Diagnosed Myeloma
Cellular and T cell engager Immunotherapy
Disease Monitoring
Myeloma Genomics and cell signaling
Myeloma Microenvironment and Immuneprofiling
Plasma Cell precursor Disorders, QoL, Patient-Reported Outcome & Supportive Care
World Conference on Lung Cancer - AUGUST 6 - 9, 2022, VIENNA, AUSTRIA
Sunday, August 7th Press Briefing
Monday, August 8th Press Briefing
Tuesday, August 9th Press Briefing
OA02 From Locally Advanced to Unresectable NSCLC: Improvement of Multimodality Tx
OA03 Molecular Targeted Treatments
OA05 The Granularity of Lung Cancer Screening Implementation
OA06 Impact of COVID-19 on Cancer Management and Protection from Vaccines
OA07 Is There Still a Role for Chemotherapy Alone in the Management of NSCLC?
OA08 Multidisciplinary Care of the Lung Cancer Patient
OA11 Optimal Patient Selection for Local Therapy in Stage IV NSCLC
OA12 Novel and Combination Strategies for SCLC
OA14 New Techniques to Improve Outcome in ES-NSCLC Patients Treated with Surgery or RT
MA06 - Resectable and Unresectable Locally Advanced Lung Cancer
MA07 - Overcoming Resistance to EGFR Inhibitors
MA08 - Patient Advocacy and Patient Preferences
MA09 - Palliative RT: The Changing Landscape with Immunotherapy & Targeted Rxs
MA10 - Updates in Thymoma
MA12 - Pathology: Tumour Diagnostics
MA13 - Update on ROS1 Inhibitors and New Pathways
MA14 - Palliative and Supportive Care - The Forgotten Trade
ESMO World Congress on Gastrointestinal Cancer (ESMO World GI 2022)
Session I: Opening Session
Session II: Cancer of the Pancreas
Session III: Cancer of the Biliary Tract
Session V: Presentation of Selected Non-Colorectal Cancer Abstracts
Session VIII: Esophageal and Gastric Cancers
Session IX: Hepatocellular Cancer
Session X: Presentation of Selected Colorectal Cancer Abstracts
Session XII: Minisymposium: Special Topics in Young Adults with Cancer
Session XV: Rectal Cancer
Session XVII: Immune Mechanisms and Immunotherapy
Session XVIII: Predicting and Managing Rare Toxicities in GI Cancer Patients
Session XIX: Presentation of Selected Abstracts on GI Cancer
Session XXII: Colorectal Cancer: Metastatic Disease
Session XXIII: Rare GI Tumors – NETs, GISTs, and Anal Cancer
EHA2022 Congress
Webcasts EHA22 Press Briefing
Presidential Symposium
Late Breaking Abstracts Session
Acute lymphoblastic leukemia
Acute myeloid leukemia
Aggressive Non-Hodgkin lymphoma
Chronic lymphocytic leukemia
Chronic myeloid leukemia
Myeloma and other monoclonal gammopathies - Clinical
Gene therapy, cellular immunotherapy and vaccination
Hodgkin lymphoma
Indolent and mantle-cell non-Hodgkin lymphoma
Myelodysplastic syndromes
Myeloproliferative neoplasms
Stem cell transplantation
ASCO Annual Meeting, June 3-7, 2022 - McCormick Place, Chicago
Late-Breaking Abstract -, Plenary - & Highlights of the Day Sessions
Lung Cancer: Oral & Poster Discussion Sessions
Head and Neck Cancer: Oral & Poster Discussion Sessions
Breast Cancer: Oral & Poster Discussion Sessions
Gynecologic Cancer: Oral & Poster Discussion Sessions
Gastrointestinal Cancer: Oral & Poster Discussion Sessions
Sarcoma Cancer: Oral & Poster Discussion Sessions
Melanoma/Skin Cancers: Oral & Poster Discussion Sessions
Central Nervous System Tumors: Oral & Poster Discussion Sessions
Genitourinary Cancer: Oral & Poster Discussion Sessions
Hematologic Malignancies: Oral & Poster Discussion Sessions
Developmental Therapeutics: Oral & Poster Discussion Sessions
Pediatric Oncology: Oral & Poster Discussion Sessions
SAMO Interdisciplinary Workshop on Breast Tumors 2022
Friday 6th May 2022 Session Diagnosis and biology (Chair: S. Aebi)
Friday 6th May 2022 Session Optimum locoregional therapy (Chair: D. Betticher)
Saturday 7th May 2022 Session “Early” (operable) breast cancer (Chair: S. Aebi)
Saturday 7th May 2022 Session Advanced breast cancer, special populations (Chair: H. Bonnefoi)
Druggable in 2022: Wie neue zielgerichtete Therapien die Behandlung bei fortgeschrittenem NSCLC verändern
3rd European Myeloma Network Meeting
Best Abstracts - Oral Presentations
Choice of clinically relevant posters
AGO - MAMMAKARZINOM STATE OF THE ART
AGO State-of-the-Art-Meeting - Interviews
Wie neue zielgerichtete Therapien die Behandlung beim fortgeschrittenen NSCLC (r)evolutionieren.
EBMT (48th Annual Meeting of the European Society for Blood and Marrow Transplantation)
Presidential Symposium
Best abstract awards
EBMT Talks: Best Abstracts
Oral session 8: CAR-T I
Oral session 9: Cellular therapies other than CARs, cell-based immune therapies, stem cell engineering
Oral session 13: CAR-T II
Oral session: Abstract finalists
Other Oral Sessions (Links to sessions only)
SAMO Highlights of the Year 2021
Chair: Rolf Stahel - Tatjana Vlajnic: Progress in Pathology; Walter Weder: Chest surgery new developments; Oliver Gautschi: Chest tumors; Radiotherapy new techniques & Radiotherapy new indications; Cristiana Sessa: Gynecological cancer
Chair: Solange Peters - Steffen Böttcher: Leukaemia; Urban Novak: Lymphoma; Stefan Aebi: Breast cancer; Aurelius Omlin: Urogenital cancer; Gastrointestinal tumors - Martin Hübner: surgical therapy; Gastrointestinal tumors - Ulrich Güller: systemic therapy
Brustrebsinfotag
Brustkrebsinfotag - Vorträge
Brustkrebsinfotag - Interviews
SAMO Masterclass I 2022
Thursday 10th March 2022 - Morning Sessions
Thursday 10th March 2022 - Afternoon Sessions
ASCO Genitourinary Cancers Symposium 2022
General Sessions
Rapid Abstract Sessions
Oral Abstract Sessions
EBMT-EHA 4th European CAR T-Cell Meeting
Best Abstracts
CAR T cell therapy: current status and new perspectives - Satellite Symposium by Bristol Myers Squibb
Sessions
ASCO Gastrointestinal Cancers Symposium
Rapid Abstract Sessions
Oral Abstract Sessions
2021
63rd ASH Annual Meeting and Exposition - December 11-14, 2021
Late-Breaking Abstracts Session
Press Briefing
ALL
AML
Acute Myeloid Leukemia: Clinical and Epidemiological
Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies
Acute Myeloid Leukemias: Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies
Lymphoma
Mantle Cell, Follicular, and Other B-Cell Lymphomas
Hodgkin Lymphomas and T/NK cell Lymphomas
Aggressive Lymphomas Prospective Therapeutic Trials
Aggressive Lymphomas: Clinical and Epidemiological
CML
Myeloproliferative Syndromes
MDS
CLL
Multiple Myeloma
Multiple Myeloma and Plasma cell Dyscrasias: Clinical and Epidemiological
Myeloma and Plasma Cell Dyscrasias: Clinical-Prospective Therapeutic Trials
Cellular Therapies
SAN ANTONIO BREAST CANCER SYMPOSIUM - December 7 - 11, 2021, San Antonio Texas
Interviews von Renate Haidinger, Brustkrebs Deutschland e.V. mit:
General Sessions 1-4
9. Interdisziplinäres Prostatakarzinom-Symposium, St. Gallen, 2. Dezember 2021
Vorträge Block I: Aktuelle Trends in Diagnose und Therapie des Prostatakarzinoms
Vorträge Block II: Indikationsstellung in der Therapie des Prostatakarzinoms und Aspekte der Lebensqualität
Kongressberichte Archiv 2021
Kongressberichte Archiv 2020
Kongressberichte Archiv 2019
Kongressberichte Archiv 2018
Kongressberichte Archiv 2017
Kalender
Krebstherapie
Alle Wirkstoffe
Behandlungsguidelines
Link to Medical Journals
Interaktionsprüfungen
Cancer Cell Line Encyclopedia
Krebserkrankungen (Entstehung, Verlauf, Therapie & Prävention)
Organisationen
Netzwerke
Fachgesellschaften
Info für PatientINNen
Science Board
Live
Video-Archiv
Breastcancer
ESMO 2022: Interviews von Renate Haidinger, Brustkrebs Deutschland e.V.
Gastrointestinal Tumours
Statement Highlights Metastatic Gastrointestinal Cancer - Dr. med. Sara De Dosso, Bellinzona & Dr. med. Alexander Siebenhüner, Schaffhausen
Kongressberichte
2023
EHA2023 Congress
Webcasts EHA2023 Press Briefing
Plenary Session
Late Breaking Abstracts Session
Acute lymphoblastic leukemia
Acute myeloid leukemia
Aggressive Non-Hodgkin lymphoma
Chronic lymphocytic leukemia
Chronic myeloid leukemia
Myeloma and other monoclonal gammopathies - Clinical
Gene therapy, cellular immunotherapy and vaccination
Hodgkin lymphoma
Indolent and mantle-cell non-Hodgkin lymphoma
Myelodysplastic syndromes
Myeloproliferative neoplasms
Stem cell transplantation
ASCO Annual Meeting, June 2-6, 2023 - McCormick Place, Chicago - Abstract Titles now available
Late-Breaking Abstract -, Plenary - & Highlights of the Day Sessions
Interviews in Kooperation mit info@ONCO-SUISSE, moderiert von Prof. Roger von Moos: Schweizer Experten fassen die ASCO Ergebnisse zusammen
Round Table und Interviews von Renate Haidinger, Brustkrebs Deutschland e.V.
Saturday, June 3 & Sunday June 4, On-Site Press Briefings
Lung Cancer: Oral & Poster Discussion Sessions
Head and Neck Cancer: Oral & Poster Discussion Sessions
Breast Cancer: Oral & Poster Discussion Sessions
Gynecologic Cancer: Oral & Poster Discussion Sessions
Gastrointestinal Cancer: Oral & Poster Discussion Sessions
Sarcoma Cancer: Oral & Poster Discussion Sessions.
Melanoma/Skin Cancers: Oral & Poster Discussion Sessions.
Central Nervous System Tumors: Oral & Poster Discussion Sessions.
Genitourinary Cancer: Oral & Poster Discussion Sessions
Hematologic Malignancies: Oral & Poster Discussion Sessions
Developmental Therapeutics: Oral & Poster Discussion Sessions
Pediatric Oncology: Oral & Poster Discussion Sessions
Comprehensive Cancer Center Zürich: Patientenakademie – Brustkrebs
Neuigkeiten in der Behandlung und Nachsorge bei Brustkrebs
18th St.Gallen International Breast Cancer Conference 2023 (SGBCC)
Interviews von Renate Haidinger, Brustkrebs Deutschland e.V. mit:
ASCO Genitourinary Cancers Symposium 2023
General Sessions
Rapid Abstract Sessions
Oral Abstract Sessions
Statements zu den Highlights des ASCO-GU
ASCO 2023 Gastrointestinal (GI) Cancers Symposium
Rapid Abstract Sessions
Oral Abstract Sessions
Links to more Abstracts
2022
64th ASH Annual Meeting and Exposition - December 10-13, 2022
Plenary Scientific Session
Late-Breaking Abstracts Session
Press Briefing
ASH 2022 Press Briefings: Treating Blood Cancers: Changing the Status Quo & New Drugs, New Targets
ASH 2022 Press Briefings: Late-Breaking Abstracts & Optimizing Pediatric Care
ALL
AML
Acute Myeloid Leukemia: Clinical and Epidemiological
Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies
Acute Myeloid Leukemias: More Abstract Links to Oral Paper Presentations
Lymphoma
Mantle Cell, Follicular, and Other B-Cell Lymphomas
Hodgkin Lymphomas and T/NK cell Lymphomas
Aggressive Lymphomas Prospective Therapeutic Trials
Aggressive Lymphomas: Clinical and Epidemiological
Lymphomas: More Abstract Links to Oral Paper Presentations
CML
Myeloproliferative Syndromes
MDS
CLL
Multiple Myeloma
Multiple Myeloma and Plasma cell Dyscrasias: Clinical and Epidemiological
Multiple Myeloma and Plasma Cell Dyscrasias: Clinical-Prospective Therapeutic Trials
Multiple Myeloma: More Abstract Links to Oral Paper Presentations
Cellular Therapies
More Abstract Links to Oral Papers (Transplantation & Gene Therapies & Outcome Research)
45th SAN ANTONIO BREAST CANCER SYMPOSIUM - December 6 - 10, 2022, San Antonio Texas
Interviews von Renate Haidinger, Brustkrebs Deutschland e.V. mit:
Statements vom SABCS 2022 für Journal Onkologie - Kooperationsprojekt Oncoletter-Journal Onkologie
More Studies from the SABCS 2022 Press Briefing
General Sessions 1-5
Cancer Academy Multiples Myelom
ESMO Congress 2022 - 9. - 13. SEPTEMBER - PARIS, FRANCE
Presidential Symposia I-III
Presidential Symposium I
Presidential Symposium II
Presidential Symposium III
BREAST CANCER
Interviews
Interviews von Renate Haidinger, Brustkrebs Deutschland e.V.
Breast cancer, early stage
Proffered Paper session: Breast cancer, early stage
Mini Oral session: Breast cancer, early stage
Breast cancer, metastatic
Proffered Paper session: Breast cancer, metastatic
Mini Oral session: Breast cancer, metastatic
LUNG CANCER & OTHER THORACIC MALIGNANCIES
Statement Highlights Lung Cancer Prof. Dr. med. Miklos Pless, Winterthur
Statement Highlights Lung Cancer Prof. Dr. med. Miklos Pless, Winterthur
Non-metastatic NSCLC and other thoracic malignancies
Proffered Paper session: Non-metastatic NSCLC and other thoracic malignancies
Mini Oral session: Non-metastatic NSCLC and other thoracic malignancies
NSCLC, metastatic
Proffered Paper session: NSCLC, metastatic
Mini Oral session: NSCLC, metastatic
HEAD & NECK CANCER
Statement Highlights Head and Neck Cancer - Assoz.-Prof. Priv.-Doz. Dr. Thorsten Füreder, Wien
Head & Neck Sessions
Proffered Paper session: Head & neck cancer
Mini Oral session: Head & neck cancer
GYNAECOLOGICAL CANCERS
Gynaecological Sessions
Proffered Paper session: Gynaecological cancers
Mini Oral session 1: Gynaecological cancers
Mini Oral session 2: Gynaecological cancers
CNS TUMOURS & SARCOMA
CNS & SARCOMA Sessions
Proffered Paper session: CNS tumours
Mini Oral session: CNS tumours
Mini Oral session: Sarcoma
GENITOURINARY TUMOURS
GU tumours, non-prostate
Proffered Paper sessions 1 & 2: GU tumours, non-prostate
Mini Oral session 1: GU tumours, non-prostate
Mini Oral session 2: GU tumours, non-prostate
GU tumours, prostate
Proffered Paper session: GU tumours, prostate
Mini Oral session: GU tumours, prostate
GASTROINTESTINAL TUMOURS
Statement Highlights Metastatic Gastrointestinal Cancer - Dr. med. Sara De Dosso, Bellinzona & Dr. med. Alexander Siebenhüner, Schaffhausen
GI, upper digestive
Proffered Paper sessions 1 & 2: GI, upper digestive
Mini Oral session: GI, upper digestive
GI, lower digestive
Proffered Paper sessions 1 & 2: GI, lower digestive
Mini Oral session: GI, lower digestive
HAEMATOLOGICAL MALIGNANCIES
Haematological malignancies Session
Mini Oral session: Haematological malignancies
MELANOMA AND OTHER SKIN TUMOURS
Statement Highlights Melanoma and other Skin Cancers - Ao. Univ.-Prof. Dr. Christoph Höller, Wien
Melanoma Sessions
Proffered Paper sessions 1 & 2: Melanoma and other skin tumours
Mini Oral session: Melanoma and other skin tumours
INVESTIGATIONAL IMMUNOTHERAPY
INVESTIGATIONAL IMMUNOTHERAPY
Proffered Paper session: Investigational immunotherapy
Mini Oral session: Investigational immunotherapy
BASIC SCIENCE & TRANSLATIONAL RESEARCH & DEVELOPMENTAL THERAPEUTICS
Basic science & translational research sessions & developmental therapeutics
Proffered Paper session: Basic science & translational research
Mini Oral session: Basic science & translational research
Mini Oral session: Developmental therapeutics
SUPPORTIVE AND PALLIATIVE CARE
Supportive and palliative care sessions
Proffered Paper session: Supportive and palliative care
Mini Oral session: Supportive and palliative care
19th International Myeloma Society Annual Meeting - Los Angeles, August 25-27, 2022
Treatment of Relapsed/Refractory Myeloma
Treatment of Newly Diagnosed Myeloma
Cellular and T cell engager Immunotherapy
Disease Monitoring
Myeloma Genomics and cell signaling
Myeloma Microenvironment and Immuneprofiling
Plasma Cell precursor Disorders, QoL, Patient-Reported Outcome & Supportive Care
World Conference on Lung Cancer - AUGUST 6 - 9, 2022, VIENNA, AUSTRIA
Sunday, August 7th Press Briefing
Monday, August 8th Press Briefing
Tuesday, August 9th Press Briefing
OA02 From Locally Advanced to Unresectable NSCLC: Improvement of Multimodality Tx
OA03 Molecular Targeted Treatments
OA05 The Granularity of Lung Cancer Screening Implementation
OA06 Impact of COVID-19 on Cancer Management and Protection from Vaccines
OA07 Is There Still a Role for Chemotherapy Alone in the Management of NSCLC?
OA08 Multidisciplinary Care of the Lung Cancer Patient
OA11 Optimal Patient Selection for Local Therapy in Stage IV NSCLC
OA12 Novel and Combination Strategies for SCLC
OA14 New Techniques to Improve Outcome in ES-NSCLC Patients Treated with Surgery or RT
MA06 - Resectable and Unresectable Locally Advanced Lung Cancer
MA07 - Overcoming Resistance to EGFR Inhibitors
MA08 - Patient Advocacy and Patient Preferences
MA09 - Palliative RT: The Changing Landscape with Immunotherapy & Targeted Rxs
MA10 - Updates in Thymoma
MA12 - Pathology: Tumour Diagnostics
MA13 - Update on ROS1 Inhibitors and New Pathways
MA14 - Palliative and Supportive Care - The Forgotten Trade
ESMO World Congress on Gastrointestinal Cancer (ESMO World GI 2022)
Session I: Opening Session
Session II: Cancer of the Pancreas
Session III: Cancer of the Biliary Tract
Session V: Presentation of Selected Non-Colorectal Cancer Abstracts
Session VIII: Esophageal and Gastric Cancers
Session IX: Hepatocellular Cancer
Session X: Presentation of Selected Colorectal Cancer Abstracts
Session XII: Minisymposium: Special Topics in Young Adults with Cancer
Session XV: Rectal Cancer
Session XVII: Immune Mechanisms and Immunotherapy
Session XVIII: Predicting and Managing Rare Toxicities in GI Cancer Patients
Session XIX: Presentation of Selected Abstracts on GI Cancer
Session XXII: Colorectal Cancer: Metastatic Disease
Session XXIII: Rare GI Tumors – NETs, GISTs, and Anal Cancer
EHA2022 Congress
Webcasts EHA22 Press Briefing
Presidential Symposium
Late Breaking Abstracts Session
Acute lymphoblastic leukemia
Acute myeloid leukemia
Aggressive Non-Hodgkin lymphoma
Chronic lymphocytic leukemia
Chronic myeloid leukemia
Myeloma and other monoclonal gammopathies - Clinical
Gene therapy, cellular immunotherapy and vaccination
Hodgkin lymphoma
Indolent and mantle-cell non-Hodgkin lymphoma
Myelodysplastic syndromes
Myeloproliferative neoplasms
Stem cell transplantation
ASCO Annual Meeting, June 3-7, 2022 - McCormick Place, Chicago
Late-Breaking Abstract -, Plenary - & Highlights of the Day Sessions
Lung Cancer: Oral & Poster Discussion Sessions
Head and Neck Cancer: Oral & Poster Discussion Sessions
Breast Cancer: Oral & Poster Discussion Sessions
Gynecologic Cancer: Oral & Poster Discussion Sessions
Gastrointestinal Cancer: Oral & Poster Discussion Sessions
Sarcoma Cancer: Oral & Poster Discussion Sessions
Melanoma/Skin Cancers: Oral & Poster Discussion Sessions
Central Nervous System Tumors: Oral & Poster Discussion Sessions
Genitourinary Cancer: Oral & Poster Discussion Sessions
Hematologic Malignancies: Oral & Poster Discussion Sessions
Developmental Therapeutics: Oral & Poster Discussion Sessions
Pediatric Oncology: Oral & Poster Discussion Sessions
SAMO Interdisciplinary Workshop on Breast Tumors 2022
Friday 6th May 2022 Session Diagnosis and biology (Chair: S. Aebi)
Friday 6th May 2022 Session Optimum locoregional therapy (Chair: D. Betticher)
Saturday 7th May 2022 Session “Early” (operable) breast cancer (Chair: S. Aebi)
Saturday 7th May 2022 Session Advanced breast cancer, special populations (Chair: H. Bonnefoi)
Druggable in 2022: Wie neue zielgerichtete Therapien die Behandlung bei fortgeschrittenem NSCLC verändern
3rd European Myeloma Network Meeting
Best Abstracts - Oral Presentations
Choice of clinically relevant posters
AGO - MAMMAKARZINOM STATE OF THE ART
AGO State-of-the-Art-Meeting - Interviews
Wie neue zielgerichtete Therapien die Behandlung beim fortgeschrittenen NSCLC (r)evolutionieren.
EBMT (48th Annual Meeting of the European Society for Blood and Marrow Transplantation)
Presidential Symposium
Best abstract awards
EBMT Talks: Best Abstracts
Oral session 8: CAR-T I
Oral session 9: Cellular therapies other than CARs, cell-based immune therapies, stem cell engineering
Oral session 13: CAR-T II
Oral session: Abstract finalists
Other Oral Sessions (Links to sessions only)
SAMO Highlights of the Year 2021
Chair: Rolf Stahel - Tatjana Vlajnic: Progress in Pathology; Walter Weder: Chest surgery new developments; Oliver Gautschi: Chest tumors; Radiotherapy new techniques & Radiotherapy new indications; Cristiana Sessa: Gynecological cancer
Chair: Solange Peters - Steffen Böttcher: Leukaemia; Urban Novak: Lymphoma; Stefan Aebi: Breast cancer; Aurelius Omlin: Urogenital cancer; Gastrointestinal tumors - Martin Hübner: surgical therapy; Gastrointestinal tumors - Ulrich Güller: systemic therapy
Brustrebsinfotag
Brustkrebsinfotag - Vorträge
Brustkrebsinfotag - Interviews
SAMO Masterclass I 2022
Thursday 10th March 2022 - Morning Sessions
Thursday 10th March 2022 - Afternoon Sessions
ASCO Genitourinary Cancers Symposium 2022
General Sessions
Rapid Abstract Sessions
Oral Abstract Sessions
EBMT-EHA 4th European CAR T-Cell Meeting
Best Abstracts
CAR T cell therapy: current status and new perspectives - Satellite Symposium by Bristol Myers Squibb
Sessions
ASCO Gastrointestinal Cancers Symposium
Rapid Abstract Sessions
Oral Abstract Sessions
2021
63rd ASH Annual Meeting and Exposition - December 11-14, 2021
Late-Breaking Abstracts Session
Press Briefing
ALL
AML
Acute Myeloid Leukemia: Clinical and Epidemiological
Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies
Acute Myeloid Leukemias: Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies
Lymphoma
Mantle Cell, Follicular, and Other B-Cell Lymphomas
Hodgkin Lymphomas and T/NK cell Lymphomas
Aggressive Lymphomas Prospective Therapeutic Trials
Aggressive Lymphomas: Clinical and Epidemiological
CML
Myeloproliferative Syndromes
MDS
CLL
Multiple Myeloma
Multiple Myeloma and Plasma cell Dyscrasias: Clinical and Epidemiological
Myeloma and Plasma Cell Dyscrasias: Clinical-Prospective Therapeutic Trials
Cellular Therapies
SAN ANTONIO BREAST CANCER SYMPOSIUM - December 7 - 11, 2021, San Antonio Texas
Interviews von Renate Haidinger, Brustkrebs Deutschland e.V. mit:
General Sessions 1-4
9. Interdisziplinäres Prostatakarzinom-Symposium, St. Gallen, 2. Dezember 2021
Vorträge Block I: Aktuelle Trends in Diagnose und Therapie des Prostatakarzinoms
Vorträge Block II: Indikationsstellung in der Therapie des Prostatakarzinoms und Aspekte der Lebensqualität
Kongressberichte Archiv 2021
Kongressberichte Archiv 2020
Kongressberichte Archiv 2019
Kongressberichte Archiv 2018
Kongressberichte Archiv 2017
Kalender
Krebstherapie
Alle Wirkstoffe
Behandlungsguidelines
Link to Medical Journals
Interaktionsprüfungen
Cancer Cell Line Encyclopedia
Krebserkrankungen (Entstehung, Verlauf, Therapie & Prävention)
Organisationen
Netzwerke
Fachgesellschaften
Info für PatientINNen
Science Board
You are using an outdated browser. The website may not be displayed correctly.
Close